A Pilot Study to Assess the Safety and Efficacy of Solifenacin (VESIcare) for Improving Urinary and Bladder Functions in Patients Undergoing Radiation Therapy of the Prostate
Phase of Trial: Phase IV
Latest Information Update: 20 Jan 2015
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 08 Jan 2015 According to the ClinicalTrials.gov record, status changed from recruiting to discontinued.
- 04 Feb 2013 New trial record
- 01 Feb 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.